Recursion Pharmaceuticals (RXRX) Kev ntsuas ntawv
Nqi dhau los$3.76Hloov kho 25 Sep 2026 21:56 UTC
Hloov-3.09%
AI kev txhais lus: RXRX
AI tshaj tawm tus nqi hom phiaj rau hnub lag luam tom ntej, kawg lub lis thiab kawg hli. Kev hloov kho raug ntsuas los ntawm tus nqi tshiab. Cov no yog kev ntsuas xav tau, tsis yog kev pab cuam lag luam.
Nqi hauv 6 hli dhau los
Premium qhia AI lub hom phiaj nqi rau 1 hnub, 1 lim tiam thiab 1 hli rau tus no thiab txhua tus stock lwm tus.
Qhib Premium🔒 Kev ntsuas kev txav chav
Kev ntsuas kev txav chav — txhua kev ntsuas dhau los nyob ze rau qhov kawg tiag tiag — yog ib feem ntawm Premium.
Qhib PremiumTxog lub tuam txhab no
Recursion Pharmaceuticals, Inc. operates as a biotechnology company. The company combines artificial intelligence with automation to conduct experimental biology in parallel for testing compounds against cellular disease models. Recursion Pharmaceuticals serves clients worldwide.
